Alexandria, VA, United States of America

James Zdrodowski

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mallinckrodt, Inc.. Active years: 2012.


% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of James Zdrodowski

Introduction: James Zdrodowski is an inventive mind located in Alexandria, VA, whose contributions to the field of pharmaceutical chemistry have led to significant advancements. With a distinct focus on the synthesis of opiate alkaloid derivatives, he exemplifies the spirit of innovation in modern science.

Latest Patents: James holds a notable patent titled "Processes for synthesis of opiate alkaloid derivatives." This invention outlines processes for the synthesis of opiate alkaloids, producing intermediate compounds that can be transformed into various biologically active alkaloids, such as buprenorphine and diprenorphine. This work not only showcases his ingenuity but also highlights his commitment to improving healthcare solutions through innovative chemical processes.

Career Highlights: Currently, James is employed by Mallinckrodt, Inc., a reputable company in the pharmaceutical industry. His role is pivotal as he engages in research and development, contributing to the creation of important medicinal compounds. Throughout his career, he has emphasized the integration of scientific research with practical applications in the medical field.

Collaborations: In his endeavors, James collaborates with talented professionals, including his coworker Anthony Mannino. Such partnerships are crucial for fostering creativity and enhancing the scope of innovation within their projects. The synergy between team members often leads to groundbreaking advancements.

Conclusion: James Zdrodowski is a distinguished inventor whose work in the synthesis of opiate alkaloids exemplifies the power of innovation in pharmaceuticals. His patent contributions not only advance scientific knowledge but also have the potential to improve patient care. As he continues his journey at Mallinckrodt, Inc., the impact of his inventions will surely resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…